Patent intelligence · US
US 9988447
Treatment of diabetes
Treatment of diabetes
Patent details — US 9988447
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 5, 2018
- Expiration
- May 31, 2038
- Applicant
- XBIOTECH INC.
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545
Quick answer
US 9988447 (Treatment of diabetes) is held by XBIOTECH INC.. Status: granted. Granted Jun 5, 2018. Expires May 31, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- XBIOTECH INC.
- Grant date
- Expiration
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K39/3955, A61K9/0019
More from XBIOTECH INC.
Related pharmaceutical patents in our USPTO index.
-
US 12116405
Arthritis treatment
granted -
US 11932688
Treatment for neoplastic diseases
granted -
US 11773157
Compositions and methods for treating and preventing Staphylococcus aureus infections
granted -
US 11529298
Cosmetic composition and its use, dermocosmetic formulation
granted -
US 11523981
Cosmetic composition and its use, dermocosmetic formulation
granted -
US 11370831
Compositions and methods for treating and preventing Staphylococcus aureus infections
granted -
US 10577410
Compositions and methods for treating and preventing Staphylococcus aureus infections
granted -
US 10294296
Treatment for neoplastic diseases
granted
Frequently asked questions
What is US patent 9988447?
US 9988447 (Treatment of diabetes) is held by XBIOTECH INC.. Status: granted. Granted Jun 5, 2018. Expires May 31, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9988447?
XBIOTECH INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 31 pharmaceutical patents for this assignee.
When does US 9988447 expire?
Our index shows an expiration date of May 31, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.